Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
41
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
61.97
Seasonality Move:
14.04%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight buying pressure.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.91 | Sell |
| 20-day SMA: | 62.82 | Sell |
| 50-day SMA: | 64.06 | Sell |
| 200-day SMA: | 59.77 | Buy |
| 8-day EMA: | 61.99 | Sell |
| 20-day EMA: | 62.64 | Sell |
| 50-day EMA: | 63.25 | Sell |
| 200-day EMA: | 60.22 | Buy |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.61 | Sell |
| Relative Strength Index (14 RSI): | 45.52 | Sell |
| Chaikin Money Flow: | 1425 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.27 - 64.09) | Sell |
| Bollinger Bands (100): | (60.51 - 66.51) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
- ProShares Ultra Nasdaq Biotechnology share price is 61.89 while BIB 8-day simple moving average is 61.91, which is a Sell signal.
- The stock price of BIB is 61.89 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 62.82, which makes it a Sell.
- ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 64.06 while BIB share price is 61.89, making it a Sell technically.
- BIB stock price is 61.89 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.77, creating a Buy signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a Sell
The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.89. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
61.89
Share Volume:
11.23K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
40.54
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?
The ProShares Ultra Nasdaq Biotechnology stock price is 61.89 USD today. -
Will BIB stock go up or go down?
ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators -
Is ProShares Ultra Nasdaq Biotechnology overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
- ProShares Ultra Nasdaq Biotechnology share price is 61.89 while BIB 8-day exponential moving average is 61.99, which is a Sell signal.
- The stock price of BIB is 61.89 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 62.64, which makes it a Sell.
- ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 63.25 while BIB share price is 61.89, making it a Sell technically.
- BIB stock price is 61.89 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 60.22, creating a Buy signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
- BIB Moving Average Covergence Divergence (MACD) indicator is -0.61, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
- ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 45.52, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
- The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (61.27 - 64.09), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
- The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (60.51 - 66.51), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.